The Gender Differences in Baseline Characteristics and Statin Intervention Among Outpatients with Coronary Heart Disease in China: The China Cholesterol Education Program-Reference-Cited by-同舟云学术

The Gender Differences in Baseline Characteristics and Statin Intervention Among Outpatients with Coronary Heart Disease in China: The China Cholesterol Education Program

Published:2009-06 Issue:6 Volume:32 Page:308-314
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Li Xiankai,Xu Yawei,Li Jue,Hu Dayi

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.20514/fullpdf

Reference33 articles.

1. Global burden of cardiovascular disease: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization;Yusuf;Circulation,2001

2. Cardiovascular disease risk factor levels and their relations to CVD rates in China-results of Sino-MONICA project;Wu;Eur J Cardiovasc Prev Rehabil,2004

3. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study;Liu;JAMA,2004

4. Serum total cholesterol and 10-year cardiovascular risk in a Chinese cohort aged 35-64 years;Wang;Zhonghua Xin Xue Guan Bing Za Zhi,2006

5. Prediction of coronary heart disease using risk factor categories;Wilson;Circulation,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycemic control and risk factors for in‐hospital mortality and vascular complications after coronary artery bypass grafting in patients with and without preexisting diabetes;Journal of Diabetes;2020-09-14

2. The Study of Clustering Effects of Behavior Risk Factors in Patients with Metabolic Syndrome in Southern China: A Cross-Sectional Study;Journal of Diabetes Research;2020-07-03

3. Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012–2018);BMC Cardiovascular Disorders;2020-04-25

4. Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China;Journal of Cardiovascular Pharmacology and Therapeutics;2020-01-10

5. Cardioprotective medication adherence among patients with coronary heart disease in China: a systematic review;Heart Asia;2019-06